About
2.15EUR-0.07 -3.15%
Closed • Updated at 14:20 GMT+00:00Market Cap$61.89M
Volume4.8K
Beta0.84
RSI52.84
Pentixapharm Holding Ag — investor relations, events, news, and company updates on 6ix.
Latest News
Feb 5 2026
Pentixapharm Announces Peer-Reviewed Phase 2 Data Back Use of PENTIXAFOR as a Superior Non-invasive PET-Diagnostic for Primary Aldosteronism
Jan 7 2026
Pentixapharm Receives FDA Feedback for Phase 3 Diagnostic Study in Hypertension
Dec 3 2025
Pentixapharm Advances Regulatory Preparations for Phase 3 PANDA Study with Radiodiagnostic Candidate 68Ga-PentixaFor in Hypertension
Oct 23 2025
Pentixapharm Strengthens Pipeline Prioritization and Improves Cost Structure
Oct 6 2025
Pentixapharm Highlights Expanding CXCR4 Radiopharmaceutical Platform with New Clinical Findings at EANM 2025
Community Chat
Ask AI
Try asking
Translate